Key result
Anti-IBV chicken scFv ZL.10 inhibits Vero cell syncytia formation and reduces nucleoprotein mRNA transcription ~83%.
Why the study?
Recombinant single-chain variable fragments (scFvs) could be potential diagnostic and therapeutic reagents to control infectious bronchitis virus (IBV) in poultry, but their neutralizing efficacy needed evaluation.
Specific and neutralizing chicken scFvs against IBV, such as ZL.10, can be produced in vitro and show potential as diagnostic and therapeutic reagents.
Avian infectious bronchitis virus (IBV), which is prevalent in many countries causing severe economic loss to the poultry industry, causes infectious bronchitis (IB) in birds. Recombinant single-chain variable fragments (scFvs) have been proven to effectively inhibit many viruses, both in vitro and in vivo, and they could be a potential diagnostic and therapeutic reagent to control IB. In this study, six anti-IBV chicken scFvs, ZL.10, ZL.64, ZL.78, ZL.80, ZL.138, and ZL.256, were obtained by screening random clones from an immune antibody library. An analysis of nucleotide sequences revealed that they represented distinctive genetic sequences and greatly varied in complementarity-determining region three of the heavy chain. Neutralization tests showed that ZL.10, which bound the S1 protein in western blots, inhibited the formation of syncytia in Vero cells 48 h post IBV infection and decreased the transcriptional level of nucleoprotein mRNA to 17.2%, while the other five scFvs, including ZL.78 and ZL.256, that bound the N protein did not. In conclusion, the results suggested that specific and neutralizing chicken scFvs against IBV, which can be safe and economical antibody reagents, can be produced in vitro through prokaryotic expression.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2015) studied Avian infectious bronchitis virus (IBV) infection. Anti-IBV chicken scFvs (ZL.10) vs. Other scFvs (ZL.78, ZL.256) was evaluated on Transcriptional level of nucleoprotein mRNA. The anti-IBV chicken scFv ZL.10 inhibited syncytia formation in Vero cells 48 hours post-infection and decreased the transcriptional level of nucleoprotein mRNA to 17.2%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: